2025 could be a breakthrough year for Mach7 shares: Here's why

At first glance, the numbers may seem unfavourable, but looks can be deceiving.

| More on:
Businessman hand with coins and sprout in network connection. Plant growing on pile of coins money. Money growth concept.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

My pick for a great share to buy in 2025 is ASX penny stock Mach7 Technologies Ltd (ASX: M7T).

Wait, wait – before you stop reading, hear me out!

Sure, the company's share price is down over 50% this year. And yes, the company posted a net loss of $8 million in FY24. I'll admit, on paper, things don't look great.

But this is a company in transition, and if it can deliver on its strategy in 2025, I think it could reward investors with a little faith.

What does Mach7 do?

Mach7 is a medical imaging company that provides services to hospitals, research facilities, and other medical institutions. The company's imaging platform is capable of integrating, standardising, and even interpreting data from many different sources. The aim is to give doctors and other healthcare professionals all the information they need to make optimal medical decisions for their patients.

How have Mach7 shares performed this year?

It's fair to say that Mach7 hasn't had the greatest 2024. At the time of writing, it looks likely that the stock price will end the year at least 50% lower. However, it has also been a transformative period for the company.

Over the past few years, Mach7 has been switching to a subscription-based business model. From a long-term perspective, this makes sense because the revenue the company generates from these contracts is actually higher. However, because it is recognised over the lifetime of the contract rather than upfront, the change dampens short-term revenues.

And that's exactly what happened in the company's FY24 results. Despite generating record numbers of new sales orders, year-on-year revenues were down 3%, and the company reported a net loss of $8 million. Frustrated shareholders—unassured by the company's insistence that the subscription-based strategy was working—decided to jump ship.

The Mach7 share price took a further hammering after the company released its first quarter FY25 business update on 31 October 2024. Although the company reaffirmed its outlook for revenue growth of 15% to 25% for FY25, investors were unimpressed with the company's sluggish first-quarter performance.

Why could 2025 be a breakout year for Mach7 shares?

A subscription-based business model can be better for both the business and its shareholders. It means the business has more confidence in its future revenues, making it easier for it to do things like budget, grow, and even pay dividends.

In FY24, recurring revenues from subscription contracts made up 72% of total revenues, a significant uplift from the 52% they contributed in FY23. This trend held up in the first quarter of FY25, where 65% of sales orders were from subscription, maintenance and other recurring fees.

If Mach7 can deliver on its revenue growth target for FY25, and if the majority of that comes from recurring revenues, this could make the company a much safer investment in years to come.

That's why, in a few years' time, I think we might all look back on 2025 as the year everything changed for Mach7.

What are the risks?

Mach7 is a small-cap growth stock, which makes it a higher-risk investment.

Because growth stocks are often junior companies with no track record of success, most of their current value depends on investors' expectations about their future profitability. Any changes to those expectations—especially those caused by changes in inflation or interest rate projections—can have an outsized impact on the prices of growth shares. This can make the share prices particularly volatile, making them suitable only for investors with a high-risk tolerance.

However, one advantage Mach7 has over other junior growth stocks is that it is debt-free. Junior companies are often highly leveraged—until they get their business off the ground, they usually have to borrow money to sustain their operations. This makes them particularly vulnerable to interest rate rises because it means they have to pay more to service that debt. For this reason, an investment in Mach7 may possibly be a little safer than other ASX growth stocks, given there is still plenty of uncertainty around what rates will look like next year.

Should you invest $1,000 in Mach7 Technologies Limited right now?

Before you buy Mach7 Technologies Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Mach7 Technologies Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 7 February 2025

Motley Fool contributor Rhys Brock has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Mach7 Technologies. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Man holding phone in front of stocks graphic
Growth Shares

2 fantastic ASX 200 growth shares to buy and hold until 2035

Let’s see why these buy-rated shares could be long term wealth generators for investors according to analysts.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Growth Shares

I think these ASX growth shares could be top buys right now

I am backing these stocks to deliver significant growth.

Read more »

Ecstatic man giving a fist pump in an office hallway.
Growth Shares

3 exciting ASX growth shares to buy with $3,000

Analysts are saying good things about these stocks. Let's dig deeper into things.

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Growth Shares

3 ASX 200 shares that have returned more than 17% a year over the last decade

These shares demonstrate why buy and hold investing can be a great strategy for investors.

Read more »

Two excited woman pointing out a bargain opportunity on a laptop.
Growth Shares

2 ASX growth shares with rapidly-rising dividends to buy now

Rapidly growing businesses are appealing for multiple reasons.

Read more »

a man in a green and gold Australian athletic kit roars ecstatically with a wide open mouth while his hands are clenched and raised as a shower of gold confetti falls in the sky around him.
Growth Shares

3 amazing Australian stocks to buy and hold until 2030

Analysts think these shares could be high-quality options for investors looking for long term picks.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Growth Shares

Why these ASX 200 growth shares could rise 40% in 12 months

Analysts are tipping these shares to deliver big returns over the next 12 months.

Read more »

A woman makes the task of vacuuming fun, leaping while she pretends it is an air guitar.
Opinions

Opinion: This is one of the best ASX growth shares to own for the next 5 years

This stock is rapidly growing, and I’m excited about it.

Read more »